EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: A randomized, double-blind, placebo-controlled trial

Annals of Plastic Surgery

Volumn 60, Issue 4, 2008, Pages 353-356

  Kashkouli, Mohsen Bahmani ^a   Salimi, Shabnam ^a   Bakhtiari, Pejman ^a   Parvaresh, Mohammad Mehdi ^a   Sanjari, Mostafa Soltan ^a   Naseripour, Masood ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Botulinum toxin; EMLA cream; Facial wrinkle

Indexed keywords

BOTULINUM TOXIN A; EMLA; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA CONJESTION; CONJUNCTIVA DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; INJECTION SITE PAIN; MALE; OCCLUSIVE DRESSING; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN MANIFESTATION; SKIN SCALING; STATISTICAL SIGNIFICANCE; TIME; VISUAL ANALOG SCALE; WRINKLE;

ADULT; ANESTHETICS, LOCAL; BOTULINUM TOXIN TYPE A; DOUBLE-BLIND METHOD; FACE; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OINTMENTS; PAIN MEASUREMENT; PRILOCAINE; PROSPECTIVE STUDIES; SKIN AGING;

EID: 41149168259     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31812f6e0f     Document Type: Article

References (21)

1. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol. 2005;6:141-150.
2. Van Laborde S, Dover JS, Moore M, et al. Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: a double-blind, randomized controlled trial. J Am Acad Dermatol. 2003;48:875-877.
3. Linder JS, Edmonson BC, Laquis SJ, et al. Skin cooling before periocular botulinum toxin A injection. Ophthal Plast Reconstr Surg. 2002;18:441-442.
4. Sarifakioglu N, Sarifakioglu E. Evaluating the effects of ice application on the pain felt during botulinum toxin type A injection. Ann Plast Surg. 2004;53:543-546.
5. Onguchi T, Takano Y, Dogru M, et al. Lidocaine tape (Penles) reduced the pain of botulinum toxin injection for Meige syndrome. Am J Ophthalmol. 2004;138:654-655.
6. Soylev MF, Kocak N, Kuvaki B, et al. Anesthesia with EMLA cream for botulinum A toxin injection into eyelids. Ophthalmologica. 2002;216:355-358.
7. Smith M, Gray BM, Ingram S, et al. Double-blind comparison of topical lignocaine-prilocaine cream (EMLA) and lignocaine infiltration for arterial cannulation in adults. Br J Anesth. 1990;65:240-242.
8. Gotsis SS, Volonaki OM, Theodossiadis GP. Percutaneous anesthesia with a lignocaine-prilocaine cream (EMLA) for eyelid skin surgery. Br J Ophthalmol. 1994;78:209-210.
9. Rogers TL, Ostrow CL. The use of EMLA cream to decrease venipuncture pain in children. J Pediatr Nurs. 2004;19:33-39.
10. Parametric sampling: Z and t tests. In: Feinstein AR, ed. Principles of Medical Statistics. New York: Chapman & Hall/CRC; 2001:238-240.
11. Kristan RW, Stasior OG. Treatment of blepharospasm with high dose brow injection of botulinum toxin. Ophthal Plast Reconstr Surg. 1987;3:25-27.
12. Gassner HG, Sherris DA. Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc. 2000;75:701-704.
13. Blitzer A, Binder WJ, Aviv JE, et al. The management of hyperfunctional facial lines with botulinum toxin: a collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg. 1997;123:389-392.
14. Egekvist H, Bjerring P. Effect of EMLA cream on skin thickness and subcutaneous venous diameter. A randomized, placebo-controlled study in children. Acta Derm Venereol. 2000;80:340-343.
15. Kuwahara RT, Skinner RB. EMLA versus ice as a topical anesthetic. Dermatol Surg. 2001;27:495-496.
16. Bjerring P, Arendt-Nielsen L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth. 1990;64:173-177.
17. Raveh T, Weinberg A, Sibirsky O, et al. Efficacy of the topical anesthetic cream, EMLA, in alleviating both needle insertion and injection pain. Ann Plast Surg. 1995;35:576-579.
18. Kuvaki B, Gonmen N, Gunenc F, et al. EMLA does not permit pain-free retrobulbar injection. Acta Anesthesiol Scand. 2003;47:739-741.
19. Eaglastein NF. Chemical injury to the eye from EMLA cream during erbium laser resurfacing. Dermatol Surg. 1999;25:590-591.
20. Bjerring P, Andersen PH, Arendt-Nielsen L. Vascular response of human skin after analgesia with EMLA cream. Br J Anaesth. 1989;63:655-660.
21. Godwin Y, Brotherston M. Hyperpigmentation following the use of EMLA cream. Br J Plast Surg. 2001;54:82-83.